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Background: Although synthetic nonviral vectors hold promise for the delivery 
of plasmid DNA, their gene-transfer efficiencies are far from matching those of 
viruses. To systematically investigate the structure-activity relationship of 
cationic lipids, a small library of cationic lipid-peptoid conjugates (lipitoids) was 
synthesized. The compounds were evaluated for their ability to form complexes 
with plasmid DNA and to mediate DNA transfer in vitro. 
Results: Lipid-peptoid conjugates were conveniently prepared in high yield 
using solid-phase synthesis. Several lipitoids condensed plasmid DNA into 
100 nm spherical particles and protected the DNA from DNase digestion. A 
subset of lipitoids with a repeated (aminoethyl, neutral, neutral) sidechain trimer 
motif conjugated with dimyristoyl phosphatidyl-ethanolamine (DMPE) mediated 
DNA transfer with high efficiency. 
Conclusions: Automated solid-phase synthesis of cationic lipids allowed the 
rapid synthesis of a diverse set of transfection reagents. The most active 
compound DMPE-(Nae-Nmpe-Nmpe), (Nae, N-aminoethyl glycine; Nmpe, 
N-p-methoxyphenethyl-glycine) is more efficient than lipofectin or DMRIE-C (two 
commercial cationic lipid transfection reagents) and is active in the presence 
and absence of serum. The activity in the presence of serum suggests potential 
for applications in vivo 
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Introduction 
(kne therapy has been receiving much attention due to 
its promise to prevent and treat man)- acquired and 
inherited diseases [l-4]. Viruses are the most effective 
DNA delivery \-chicle for gene therapy, but they suffer 
from a number of undesirable properties for therapeutic 
applications, such as uncertainties about safety, immuno- 
genicit);, limited packaging capacity for genetic material 
and manufacturing difficulties. Konviral DNA deli\.ery 
\ ehicles have, therefore, also been under development in 
an effort to overcome these barriers [S-8]. There are 
mainly two classes of compounds used for the nonviral 
dcli\.ery of DK.1: firstly, cationic polymers such as poly- 
lyrines [c),lO], cationic peptides [11,12], proteins [13,14], 
glucaramide-based polymers [15], polyetheleyneimines 
[l&17], or cationic dendrimers [1X,19], and secondly, 
monocationic or poll-cationic lipids [X&-23] such as lipo- 
fcctin. lipofect-amine. lipofectace, and DI\IKIE-C. Both 
of these classes of compounds spontaneously form com- 
plexes with DN,-2 (commonly called polyplex and 
lipoplex) through electrostatic interactions. condensing 
the L1NA into a compact form, and protecting it from 
enzymatic degradation. So far, however, the existing 
non\.iral DNA-deli\rcr>- vehicles are far from matching 
the efficiency of viruses for DNA transfer, and often 
exhibit high cellular toxicity. Because a wriet\- of cat- 
ionic structures are efficient at transfccting cells. we 
decided to systematically investigate a diverse family of 
cationic lipids to find molecules with high DN,L\- transfer 
efficiency and low c);totoxicit)r. In order to rapidly syn- 
thesize a wide variet\- of cationic lipids. \vc used the 
solid-phase peptoid-s>-nthesis methods that were devcl- 
oped for combinatorial drug discovery (24-261. 
In this report, the term peptoid refers to poly :Y-substi- 
tuted glycines. Because peptoids contain a secondar) 
amide linkage rather than the primary amide bond found 
in peptides and proteins, peptoids are resistant to proteo- 
Il;tic enzymes [27], and can be employed for applications 
in C~CO where peptides fail as a result of enzymatic degra- 
dation. Peptoids are prepared by solid-phase synthesis 
using a submonomer method that utilic.es inexpcnsi\e 
starting materials (primary amines and bromoacetic acid) 
as building blocks, rather than costly monomers such as 
protected amino acids for peptide synthesis. In addition, a 
much wider choice of functional groups can be rcadil? 
introduced as sidechains, generating peptoid oligomers 
with diverse physical. chemical and biological properties. 
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Scheme for synthesis of peptoids (poly N-substituted glycines) on the 
solid phase using the submonomer method. Each peptoid monomer is 
constructed on polymer beads by coupling bromoacetic acid to a 
secondary amine on the resin, followed by S,2 displacement of the 
bromide by a desired amine. DIC, diisopropylcarbodiimide; DMF, 
dimthylformamide; DMSO, dimethylsulfoxide. 
Automated synthesis can be used to generate libraries 
with little difficulty. To obtain new cationic-lipid com- 
pounds, phospholipids have been incorporated as 
sidechains into the peptoid structure using the sub- 
monomer synthetic method on solid phase, affording a 
new class of lipid compounds called lipopeptoids or lipi- 
toids. These lipitoids have been evaluated for their ability 
to mediate DNA transfer to cells. 
Results 
Synthesis of lipitoids 
Peptoids are readily synthesized on the solid phase using 
the submonomer method [Z&26]. Each N-substituted 
glycine monomer is constructed on polymer beads by cou- 
pling bromoacetic acid to secondary amine on the resin, 
followed by the S,Z displacement of the bromide by a 
desired amine (Figure 1). These two steps are repeated 
using a fully automated robotic synthesizer until the 
desired sequence is completed. Lipitoids were synthe- 
sized by first elaborating the peptoid oligomer and cou- 
pling the lipid via its amino group as the last (amino- 
terminal) submonomer. Phosphatidylethanolamine in 1.5% 
(v/v) methanol in chlorobenzene was treated with 0.95 
molar equivalents of KOH to liberate the free amine 
moiety prior to lipid addition. Due to the poor solubility of 
the phosphatidylethanolamine molecules, this material 
was added at 0.2 M concentration in 15% (v/v) methanol 
in chlorobenzene, and, accordingly, a longer (16 h) reac- 
tion time was used. The bromoacetylation steps and the 
S,2 displacement steps proceeded smoothly, generally 
with > 98% yield at each step. The final displacement step 
by the phospholipid resulted in a somewhat lower yield of 
approximately 8.5%. This is probably due to the lower con- 
centration of the nucleophile (phospholipid) and a differ- 
ent solvent system. Treatment of the resin with 95% (v/v) 
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Analysis of lipitoid using reverse-phase-HPLC and electrospray 
ionization mass spectroscopy. (a) HPLC trace of (i) crude 
(Nae-Nmpe-Nmpe),, (ii) crude DMPE-(Nae-Nmpe-Nmpe),, and (iii) 
purified DMPE-(Nae-Nmpe-Nmpe), (14). A linear gradient of 
5-95Yo (v/v) solvent B in solvent A over 40 min was used at a flow 
rate of 100 @/min (solvent A, 0.10/o TFA in water; solvent B, 0.1 o/, 
TFA in acetonitrile) and a column temperature of 60°C. 
(b) Electrospray ionization mass spectrum of lipitoid 14. The 
analysis was performed at a cone voltage of 30 V. 
trifluoroacetic acid (TFA) in water at 25°C for 20 min 
resulted in cleavage of the desired peptoid from the resin 
and removal of the tert-butoxy carbonyl (BOC) group on 
the IV-(Z-aminoethyl)glycines (#ae) and N-(j-amino- 
propyl)glycines as expected. The crude products were 
purified using reverse-phase preparative high-perfor- 
mance liquid chromatography (HPLC). Analytical reverse- 
phase HPLC revealed > 95% homogeneity for the 
purified lipitoids. In order to make stock solutions, lipi- 
toids were dissolved in water at a concentration of 5 mM 
and sonicated for 1 min, resulting in a clear solution. 
Figure 2a shows the HPLC traces of crude (;Vae-ilimpe- 
iVmpe)3, crude DMPE-(A’ae-Nmpe-Nmpe)3, and purified 
DMPE-(iVae-Nmpe-Nmpe)3 (14: Nmpe, :V-p-methoxy- 
phenethyl-glycine; DMPE, dimirystoyl phosphotidyl- 
ethanolamine). The electrospray ionization mass spectrum 
displays the multiply charged species derived from the 
lipitoid 14, which were used to determine the molecular 
weight of 14 (Figure Zb). The observed molecular weights 
were in good agreement with the calculated values for all 
the compounds that we prepared (Table 1). 
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Table 1 
(a) Synthetic cationic lipitoids for gene transfer: repeating monomer motif. 
Molecular weiaht 
Lipid* n+ Designator* Calculated founds 
1 DMPE 
2 DMPE 
3 DMPE 
4 DMPE 
5 DPPE 
6 DPPE 
7 DMPE 
8 DPPE 
9 DPPE 
10 DPPE 
P-Aminoethyl 
2-Aminoethyl 
P-Aminoethyl 
P-Aminoethyl 
2-Aminoethyl 
3-Aminopropyl 
3-Aminopropyl 
3-Aminopropyl 
3-Aminopropyl 
3-Aminopropyl 
2 DMPE-(Nae), 
4 DMPE-(Nae), 
10 DMPE-(Nae),, 
4 DPPE-(Nae), 
IO DPPE-(Nae),, 
4 DMPE-(Nap), 
10 DMPE-(Nap),, 
2 DPPE-(Nap), 
4 DPPE-(Nap), 
10 DPPE-(Nap),, 
893.2 ND 
1093.4 1092.9 
1694.1 1693.4 
1149.5 1 148.9 
1750.2 1749.4 
1 149.2 1148.8 
1834.5 1833.7 
977.4 ND 
1205.6 1205.9 
1890.6 1889.8 
(b) Synthetic cationic lipitoids for gene transfer: repeating trimer motif. 
Lipid 
Lipid* R n+ 
11 DMPE 2-Phenethyl 3 
12 DMPE (S)-1 -phenylethyl 3 
13 DMPE p-MeO-phenethyl 2 
14 DMPE p-MeO-phenethyl 3 
15 DMPE p-MeO-phenethyl 4 
16 DMPE p-MeO-phenethyl 8 
17 DMPE p-MeO-phenethyl 12 
18 DOPE p-MeO-phenethyl 3 
19 DMPE Pentyl 3 
20 DOPE P-Methylbutyl 3 
21 DMPE 3-Methylbutyl 3 
22 DOPE 3-Methylbutyl 3 
*DMPE, dimyristoyl phosphatidylethanolamine; DPPE, dipalmitoyl 
phosphatidylethanolamine; DOPE, dioleoyl phosphatidylethanolamine. 
+Note that these values also represent the number of formal positive 
charges on each lipitoid. *Nae, N-(2-aminoethyl)glycine; Nap, 
N-(3.amino-propyl)glycine; Npe, N-(2-phenylethyl)glycine; Nspe, 
Transfection efficiency 
‘1’0 e~aluatc the ability of the lipitoids to mediate I>NA 
transfer irr cifro, transfection experiments \? ere performed 
using a luciferase reporter plasmid and the HT1080 cell 
line in the presence of 10% fetal calf strum in the media. 
DiYA-lipitoid complexes were formed by mixing lipitoid 
with the DNAat a stoichiometry expressed as a charge 
Designator* Calculated founds 
DMPE-(NaeNpeNpe), 1960.5 1959.5 
DMPE-(NaeNspeNspe), 1960.5 1959.6 
DMPE-(NaeNmpeNmpe), 1658.1 1658.0 
DMPE-(NaeNmpeNmpe), 2140.7 2139.7 
DMPE-(NaeNmpeNmpe), 2623.2 2622.0 
DMPE-(NaeNmpeNmpe), 4553.5 4551.3 
DMPE-(NaeNmpeNmpe),2 6483.8 6480.8 
DOPE-(NaeNmpeNmpe), 2248.8 2248.0 
DMPE-(NaeNpnNpn), 1756.4 1755.4 
DOPE-(NaeNmbNmb), 1864.5 1864.4 
DMPE-(NaeNiaNia), 1756.4 1755.5 
DOPE-(NaeNiaNia), 1864.5 1864.3 
Molecular weiaht 
N-[(S)-1 -phenylethyllglycine; Nmpe, N-[2-(4’.methoxyl- 
phenyl)ethyllglycine; Npn, IV-pentylglycine; Nmb, N-@methylbutyl)- 
glycine; Nia, N-(3.methylbutyl)glycine; §by electrospray mass 
spectrometry. ND, not determined. 
ratio (+/-) between the lipitoid positive charge and the 
DNA ncgati\ e charge. (2omparison of the transfection 
activity of the different lipitoids was carried out at a 2/l 
charge ratio. (:omplexes lucre prepared by mixing cq~~il 
~olumcs of the DNA and lipitoid solutions, which gcner- 
ally affording clear solutions without any dctectablc pre- 
cipitates. The transfcction results are shown in Figure 3. 
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Comparison of DNA transfection mediated by synthetic cationic lipids 
and lipitoids. Transfections were mediated by lipitoids, DMRIE-C, and 
lipofectin in HTlO80 cells in the presence of 10% fetal calf serum. A +/- 
charge ratio of 2/l was used for formation of all complexes. Luciferase 
was quantified as described in the Materials and methods section. 
Lipitoids with only positively charged sidechains (Table la, 
l-10) did not mediate significant DNA transfer, regardless 
of the sidechain length (Z-aminoethyl versus 3-aminopropyl) 
or the lipid moiety (DhlPE versus dipalmitoyl phospho- 
tidylethanolamine [DPPE]). In contrast, the lipitoids with a 
(Z-aminoethyl, neutral, neutral) trimer motif (Table lb, ll- 
-22) mediated DNA transfer to varying degrees in the pres- 
ence of serum, and their efficiencies were generally higher 
than that of lipofectin. In fact, lipitoid 21 showed 10 to 20 
times higher efficiency than lipofectin and threefold higher 
efficiency than DMRIE-C in HT1080 cells. These lipitoids 
also worked in the absence of serum (data not shown). Com- 
parison of the lipitoids containing DhIPE conjugated with 
the nine-mer amphiphilic peptoids (11, 12, 14, 19, 21) indi- 
cates that either aromatic or aliphatic sidechains Q-methoxy- 
phenylethyl and branched or straight pentyl group) in the 
peptoid moiety were both effective, although the gel-mobil- 
ity shift assay and the DNase I digestion assay demonstrated 
that the lipitoids with aromatic sidechains formed stronger 
complexes with DNA (see below). \Vith respect to effect of 
the length of the peptoid moiety among the lipitoids 
DRlPE-(~\7ae-~Vmpe-~~rmpe), (n = 2, 3, 4, 8, 12 for 13, 14, 
15, 16 and 17, respectively), the nine-mer (14, n = 3) was 
found to be the most active. Finally, DMPE was consis- 
tently more effective than dioleovl phosphotidylethanol- 
amine (DOPE) as the lipid moiety in these lipitoids. 
Optimization of transfection conditions 
In an effort to optimize the DNA transfection efficiency, 
lipitoid 14 and DKA were complexed at different +/- 
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J 
Effect of altering the +/- charge ratio of lipitoid 14-DNA on 
transfection efficiency on HT1080 cells. Shaded bars, with 10% serum 
in DMEM; open bars, without serum in OptiMEM. The amount of 
luciferase in 20 pl cell lysate was quantified as described in the 
Materials and methods section. 
charge ratios ranging from 8/l to 05/l. and the transfection 
ability evaluated in the presence and absence of serum. A 
+/- ratio of 2/l was found to be the most efficient at trans- 
fecting cells. Serum did not have a significant influence on 
efficiency at the ratios tested (Figure 3). 
Cell dependence of transfection and toxicity 
Efficiency and cell toxicity of transfection mediation com- 
pounds have been found to depend on the cell lines used. 
For example, we studied the transfection efficiency of lipi- 
toids 14 and 21 on COS6M, iKIH3T3 and HT1080 cell 
lines using the optimal lipitoid/DNA ratio of Z/l. Lipitoid 
21 was very efficient (Figure 3) and also barely toxic on 
HT1080 cells, but not very efficient on NIH3T3 cells. In 
contrast, lipitoid 14 showed very high activity and was 
essentially nontoxic on NIH3T3 cells. This was especially 
true in the absence of serum when compared with lipitoid 
21, DRIRIE-C, or lipofectin (Figure Sa). W:hen COS6hl 
cells were transfected, lipitoids 14 and 21 were comparable 
or slightly less effective than transfection with DMRIE-C, 
although both lipitoids worked much better than lipofectin 
(Figure 5b). \$‘hen green fluorescent protein (GFP) WIS 
used to evaluate the transfection efficiency for COS611 
cells, lipitoid 21 consistently resulted in a higher percent- 
age of fluorescent cells (approximately 30%) than lipo- 
fectin, but produced approximately as many fluorescent 
cells as DRIRIE-C (Figure 6). 
Electron microscopy of lipitoid and lipitoid-DNA complexes 
Because size measurement of a clear solution of lipitoid 14 
by dynamic light scattering failed, we used negative-stain 
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Comparison of transfection efficiency in different cell lines. 
Transfection was mediated by lipitoids 14, 21, DMRIE-C, or lipofectin 
on (a) NIH3T3 cells and on (b) COSGM cells. Shaded bars, with 10% 
serum in DMEM; open bars, without serum in OptiMEM. A +/- charge 
ratio of 2/l was used for formation of all complexes. Luciferase and 
total protein in cell lysate were quantified as described in the Materials 
and methods section, and data were expressed in ng of luciferase per 
mg of total protein. 
Figure 6 
Expression of green fluorescent protein (GFP) 
in COSGM cells. Transfection of COSGM 
cells using a plasmid coding for the GFP gene 
mediated by (a) lipitoid 21, (b) DMRIE-C, or 
(c) lipofectin. A +/- charge ratio of 2/l was 
used for formation of all complexes. 
electron microscopy to characterize the lipitoids. Analysis 
of lipitoid 14 revealed aggregates of mostly qlindrical 
micelles with some spherical micelles, whose diameters 
were 10-15 nm (Figure 721). 
\Vhen complexed with plasmid DKA, lipitoid 14 under- 
went a dramatic morphological change. Electron micro- 
scopy showed the formation of relatively homogeneous, 
spherical particles with diameters ranging from SO-150 nm 
for a 2/l (+/-) ratio of 14/DSA complex (Figure 7b). 
Particle size and zeta potential 
Particle size and zeta potential of complexes of plasmid 
DNA with different amount of lipitoid 14 were measured 
using dynamic light scattering and Doppler electrophoretic 
light scattering analysis (Figure 8). As expected. the particle 
size became smaller as more lipitoid 14 became associated 
with DNA. decreasing to the smallest diameter of approxi- 
mately 120 nm at a +/- charge ratio of 2/l. \Vhen the charge 
ratio increased further, the particle size increased slightly. 
The zeta potential (a measurement of particle surface 
charge) of the complex increased steadily as the lipitoid/ 
DIiA ratio increased, and charge neutralization ~vas realized 
at a lipitoid/DNX charge ratio between 05 and 1 (Figure 8). 
A similar trend was observed for complex formation 
between lipitoid 21 and DNA: the particle size reached a 
minimum diameter of 120 nm when the +/- charge ratio was 
around Z/l, and slightly increased at the higher charge ratio. 
Gel-mobility-shift assay 
\Vhen negative charges in the phosphate backbone of DNA 
are neutralized by positively charged lipitoid upon complex 
formation, the resulting electroneutral or positively charged 
complexes do not migrate towards the cathode during 
agarose gel electrophoresis. Gel mobility shift assa)-s 
demonstrated that the plasmid DKX \vas completely 
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Figure 7 
(b) 
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Electron microscopy of lipitoid 14 and lipitold 
I4-DNA complex. Transmission electron 
microscopy (a) of lipitoid 14 and (b) of lipitoid 
14-DNA complex at a +/- charge ratio of 2/l. 
Scale bars, 200 nm. 
retained in the loading well when mixed with lipitoid 14 at 
a +/- charge ratio greater than or equal to l/l (Figure 9a). 
In contrast, lipitoid 21 did not form a strong and/or stable 
complex with the plasmid DNA (Figure Oa), and a +/- 
charge ratio of 8/l \~as required to achieve complete rctar- 
dation of the plasmid DNA, although electron microscop\ 
revealed spherical lipitoid-DNA complex formation at +/- 
charge ratios of both 2/l and 4/l (data not shown). 
Complex sensitivity to DNase I digestion 
Lipitoid-DNA complexes with a +/- charge ratio of ,2/l 
were treated with DNase 1, follo\vcd by 1% sodium dodecyl 
sulfate (SDS) to inactivate the nuclcase and to liberate the 
DNA from the lipitoids. ‘The results were analyzed using 
agarose gel electrophoresis. Among all the lipitoids in 
Table 1 b, lipitoids containing the ;V~ae-‘Z’mpc-~~~lnpe motif 
(13, 14, 15, 16, 17 and 18) protected DNA to a higher extent 
than lipitoids containing other structural motifs regardless 
of the length of the lipitoid or the structure of phospholipid 
moiety (data not shown). In fact, when the effect of charge 
ratio was examined for lipitoid 14, no significant degrada- 
tion was observed even for the complex with a +/- charge 
ratio as low as l/Z, although the supcrcoiled conformation 
was maintained somewhat better at higher charge ratios 
(Figure 9b). In contrast, lipitoid 21 poorly protected DNA 
from DNase I digestion (Figure C)b), which is consistent 
with the fact that lipitoid 21 did not form a stable complex 
with the plasmid DNA (according to the g&shift assay). 
Discussion 
Although a variety of cationic lipids can mediate DNA 
transfer to cells, few systematic studies have been carried 
out to assess the structure-activity relationship of these 
lipids [28-301, which is partly because the synthesis of 
lipids is often time consuming and labor intensive. Solid- 
phase synthesis of lipid analogs offers an attractive alterna- 
tive, as the reaction workup is greatly simplified [Al]. In 
addition, solid-phase chemistries and combinatorial library 
approaches facilitate the rapid generation of a wide array of 
structures. ‘I‘hc ‘peptoid approach’ can xccss an extremely 
diverse family of structures that are protease resistant. A 
separate study in our laboratory revealed that high molecu- 
lar weight peptoids with certain repeating motifs are cffec- 
ti1.e DNA-delivery vehicles [32]. To gain further insight 
into the requirements for efficient DNA transfer by cationic 
lipids and to expand the scope of peptoid chemistry, \ve 
ha1.c prepared a small library of peptoid-phospholipid con- 
jugates (lipitoids). The first series has a peptoid moiety con- 
sisting only of positively charged sidechains (Table la. 
l-10). These are analogous to polylysine-lipid conJugates 
and certain polycationic lipids [M-3.5]. The second series 
has neutral sidechains as \~ell as positively charged 
sidechains. Specifically. w-e have studied a repeating trimer 
motif with one aminoethyl sidechain and two neutral 
sidechains (,\‘a~-:Vxx-&kx) that is effective in gent trans- 
fer (‘l’able lb, 11-22). As a lipid moiety, phosphatidyl- 
cthanolamine was chosen for two reasons. l;irst, naturally 
occurring lipids can ameliorate the toxic effect general]) 
associated with unnatural synthetic cationic lipids. Scc- 
ondly, phosphatidylethanolrlminc has a primary amino 
group, and thus is compatible with the submonomer 
method for peptoid preparation. \\re note that many diffcr- 
cnt classes of synthetic or natural lipids can also bc incor- 
porated by direct or indirect coupling methods, ho\\,ever, 
thanks to the flexibility of pcptoid chemistry. 
Synthesis of the lipitoids \vas performed without difficul- 
ties. Because we used solid-phase synthesis, no tedious 
handling of lipids or \\.ork-up of the reaction was necessary, 
and thus this methodology greatly facilitated the synthesis 
of lipid molecules. In addition, the resulting products were 
readily purified to homogeneity using re\ erse-phase 
HPLC, because the desired lipitoid product is much more 
lipophilic than the impurity (presumably unconjugated 
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Fiaurn A - .a-.- - the lipitoids were confirmed using clcctrospray mass spec- 
trometry (Figure 2b, ‘Fable 1). 
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Particle size and zeta potential of lipitoid-DNA complexes. Effect of 
altering the +/- charge ratio of 14/DNA complex on the complex 
particle size (open circles) and zeta potential (filled circles). 
Re have found that the transfection cfficienq of the lip- 
toids is dependent both on the lipid moiety and on the 
sequence and length of the peptoid moiety. ‘I’hc lipid 
moiety is critical for the activity, as nine-mer peptoids such 
as (Sac-~Vmpe-;\‘mpe),j have hccn shotvn to fail to con- 
dense DiXA and to transfer it to cells. ‘I‘his is probabl) due 
to the lipid’s ability to self-assemhlc through hy-drophobic 
interactions to generate a positively charged cstended 
surke. Furthermore, the lipid moiety COLII~ also pIa! an 
active role in releasing the D&A into the c) toplasm 
through interactions with cell membranes, because the lip 
itoids with longer peptoids are less cffecti\.c (compare 14 
and 17). DRIPE is more effective than DOPE as >I lipid 
moiety. ‘I’his could relate to the shape of the alkyl chains, 
their hydrophobicit);, and/or the phase-transition tcmperz 
turc of these lipids. Although DOPE and/or cholesterol arc 
often added to the formulation of cationic lipids for I1N.1 
deliver);, the)- did not enhance the transfection activity of 
the lipitoids (data not shown). 
pcptoid) that do not contain the lipid moiety. HPLC traces The cationic peptoid moiety does not only interact with 
of crude (,~de-~~inpe-l~mmpe),~, crude DMPE-(Nae-LVmpe- L>NA electrostatically - it must also acti\.cly mediate 
:Vmpe),, and purified DMPE-(lVae-1Vmpe-Armpe)3 (14) DNA transfer. The lipitoids with only positively char& 
indicate the high yield of nine-mer synthesis and the ease sidcchains did not mediate DN.L\ transfer significantly. 
of isolation of the lipitoids (Figure Za). The structures of despite the fact that these lipitoids formed a complex \vith 
Figure 9 
Studies of DNA-lipitold complex formation 
and DNA protection from DNase I by lipitoid. 
(a) Agarose gel-shift assay. The plasmid DNA 
(1 pg) and different amount of lipitoid 14 and 
21 were mixed, followed by electrophoresis. 
Charge ratios (+I-) are indicated by the 
values above each lane. (b) DNase I 
protection assay. Lipitoid-DNA complexes 
were treated with DNase I and then 1% SDS, 
followed by electrophoresis. 
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the plasmid DNA and protected it from enzymatic degra- 
dation. In contrast, lipitoids with an amphiphilic trimer 
motif (Table lb, 11-22) did mediate DNA transfer to 
varying degrees, regardless of the neutral sidechains in the 
peptoid moiety. Consistent with this result, the high mol- 
ecular weight peptoids containing an amphiphilic trimer 
motif were efficient DNA transfer agents whereas the 
peptoids containing only positively charged sidechains 
were not [32]. 
Lipitoid 14 showed the highest DNA-transfer efficiency at 
a +/- charge ratio of Z/l. The particle measurement exper- 
iment demonstrated that lipitoid 14 condenses DNA the 
most at this charge ratio. The low efficiency at the lower 
charge ratio does not result from incomplete charge neu- 
tralization, because the gel-shift assay, as well as the zeta 
potential measurement, confirmed the formation of a posi- 
tively charged complex at a +/- charge ratio greater than or 
equal to l/l. Also, the DBase I digestion assay demon- 
strated that lipitoid 14 can protect DNA effectively at a 
+/-charge ratio as low as l/Z. Thus, protection from serum 
degradation is not the only determinant of transfection 
efficiency. It is likely that the lipitoid also facilitates entry 
of DNA into the cytoplasm. Transfection efficiency and 
toxicity of lipitoids depend on the cell type, as is often the 
case with other cationic transfection agents. Lipitoids 14O 
and 21 showed considerably better activity than lipofectin 
for all three cell lines used in this study, however, and 
were also more efficient than DAIRIE-C depending on 
the cell line tested. 
To characterize the lipitoid-DNA complex particles, 
electron microscopy and light scattering studies were 
performed. Upon rehydration, lipitoid 14 resulted in a 
clear solution. In contrast to many cationic lipids, which 
form liposomes in aqueous media [36], lipitoid 14 formed 
aggregates of mostly cylindrical micelles with some 
spherical micelles. The diameters of these assemblies 
were lo-15 nm (Figure 6). Electron microscopy revealed 
that lipitoid 14 and 21 both formed relatively homoge- 
nous, individuated spherical particles whose diameters 
were around 50-150 nm, when complexed with DNA 
at a 2/l (+I-) charge ratio. The homogeneity of the 
sample is an indication that there is little uncomplexed 
lipitoid present in the sample. These results are consis- 
tent with the data from the particle size measurement by 
dynamic light scattering. Although the fine structure of 
these complexes has yet to be deter .mined, plasmid DNA 
is probably encapsulated inside the complex formed with 
lipitoid 14, because the DNA was well protected in the 
complex from DNase I. These results are in contrast to 
the fact that formulation of DKA with common cationic 
transfection agents often results in a heterogeneous pop- 
ulation of complexes with different shapes and different 
sizes including insoluble aggregates even under opti- 
mized conditions [37-391. 
Significance 
Gene therapy promises to prevent and treat many dis- 
eases. Although viruses are the most effective DNA- 
delivery vehicles for gene therapy, there are a number of 
drawbacks to their use in therapeutic applications, such 
as uncertainties about safety. Consequently, synthetic 
nonviral vectors are also being developed. In order to 
systematically investigate the structural requirement of 
cationic lipids for efficient nontoxic DNA transfer to 
cells, a small library of lipitoids (peptoid-phospholipid 
conjugates) has been generated. This is one of the first 
attempts to synthesize a wide variety of lipid structures 
on the solid phase. The submonomer synthesis methods 
of peptoid chemistry are well suited for this purpose. We 
have found that the transfection efficiency of the lipitoids 
is dependent both on the lipid moiety and on the 
sequence and length of the peptoid moiety. DMPE- 
(Nae-Nxx-Nxx)3 (DMPE, dimirystoyl phosphotidyl- 
ethanolamine; Nae, N-aminoethyl glycine; Nxx, glycine 
with a neutral sidechain on the nitrogen) was the most 
effective structure studied. We expect that the amphi- 
philicity of the peptoid moiety plays an important role in 
transferring DNA into cells. These lipitoids mediate 
DNA transfection not only in the absence of the serum 
but also in its presence, and their transfection efficiencies 
are generally higher than those of lipofectin or 
DMRIE-C. The activity in the presence of serum offers 
the potential for its use in DNA-delivery applications in 
viva. Furthermore, lipitoids are virtually nontoxic to cells 
under the optimized conditions. Structural studies of the 
lipitoid-DNA complexes revealed the formation of rela- 
tively homogeneous spherical particles, which protect the 
nucleic acid from DNase degradation. These particles 
are expected to serve as a core structure onto which 
additional components such as targeting ligands and/or 
colloidal stabilizers could be grafted in order to construct 
an artificial virus using a modular approach. Also, it 
should be possible to target these particles to specific 
organs by formulation with another lipid that is conju- 
gated with appropriate targeting ligands. The design and 
synthesis of targeting ligands and the development of the 
conjugation chemistry for the lipitoids, as well as in vivo 
transfection assays are currently in progress. 
Materials and methods 
Materials 
DMPE and DPPE were purchased from Genzyme (Cambridge, MA), 
DOPE from Avanti Polar Lipids Inc. (Alabaster, AK), and cholesterol 
from CalBiochem (San Diego, CA). Fmoc-Rink amide resin was pur- 
chased from NovaBiochem (San Diego, CA). Solvents (N,N’-dimethyl- 
formamide (DMF), dimethylsufoxide (DMSO), 1,2-dichloroethane 
(DCE), dicloromethane (DCM), methanol, 1,4-dioxane, acetic acid, ace- 
tonitrile) were purchased from Fisher Scientific (Pittsburgh, PA). 
Amines (phenethylamine, 2-(4’.methoxyphenyl)ethylamine, amylamine, 
isoamyl-amine, and ethylenediamine), other reagents (piperidine, N,K- 
diisopropylcarbodiimide (DIG), bromoacetic acid, trifluoroacetic acid 
(TFA), and di-terf-butyl dicarbonate), and chlorobenzene were pur- 
chased from Aldrich (Milwaukee, WI). Plasmid DNA pCMV-km-LUC 
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was prepared as described by Murphy et al. 1321. Green fluorescent 
protein plasmid, pEGFP-Nl, was purchased from Clontech (Palo Alto, 
CA). Tissue culture cells HT1080 (human fibrosarcoma), COSGM 
(African green monkey kidney), and NIH3T3 (murine fibroblasts) were 
obtarned from ATCC. Dulbecco’s modified Eagle’s medium (DMEM), 
sodium pyruvate, L-glutamine, and Dulbecco’s phosphate-buffered 
saline (DPBS) were purchased from JRH Bioscience (Lenexa, KS). 
Lysis buffer and the luciferase assay kit were purchased from Promega 
(Madison, WI). OptiMEM, Lipofectin (a 1 :l [w/w] mixture of N-[l-(2,3- 
dioleyloxy)propyll-N,N,N-trimethylammonium chloride (DOTMA) and 
dioleyl phosphatidylethanolamine (DOPE)) and DMRIE-C (a 1:l molar 
ratio of 1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bro- 
mrde (DMRIE) and cholesterol) were purchased from Gibco/BRL 
(Gaithersburg, MD). Fetal calf serum (FCS) was purchased from 
Summit Biotechnologies (Fort Collins, CO). DNase I was purchased 
from Boehringer Mannheim (Indianapolis, IN). Ethylenediamine and 
13diaminopropane monoprotected with tert-butoxycarbonyl group 
(t-BOC) were prepared by the method of Krapcho and Kuell 1401. 
Chemical synthesis of lipitoid 
In order to construct A!-(2aminoethyl)-glycine and IV-(3.aminopropyl) 
glycrne, mono-t-BOC ethylenediamine and 1,3-diaminopropane were 
used as submonomers, respectively, whose BOC protecting groups 
are ultimately removed at the cleavage step by 95% (v/v) TFA in water. 
Peptoids were synthesized on 100 mg (50 umol) of Rink amide resin 
and elaborated under normal submonomer conditions until the second 
to the last position using an automated robotic synthesizer [24-261. 
The lipid was then introduced at the amino terminus as follows. The 
amino-termrnal amino group was acylated at 35’C for 45 min with 
0.85 ml of 1.2 M bromoacetic acid in DMF and 0.2 ml of DIC. The resin 
was thoroughly washed with DMF (3 x 2 ml). DMPE (254 mg) was sus- 
pended In 2 ml of 15% (v/v) methanol in chlorobenzene, and treated 
with 0.95 equivalent (30 ul) of 12.8 N aqueous KOH. The resulting 
0.2 M solution of DMPE was added to the bromoacetylated peptoid on 
resin, and the reactron was gently agitated for 14 h at 35°C. The resin 
was thoroughly washed with 15% (v/v) methanol (6 x 2 ml) in 
chlorobenzene to remove the unreacted DMPE, followed by DCM 
wash (2 x 2 ml). The lipitoid was cleaved from the resin and depro- 
tected using 950/o (v/v) TFA in water, and lyophilized to afford the crude 
product. The lyphophilized crude lipitoid was dissolved in 5 ml of 50% 
(v/v) acetonirile in water, and the solution was applied to a Delta-PakTM 
C4 (15 pm, 300A) equilibrated with 80% (v/v) solvent B (0.1% [v/v] 
TFA in acetonitrile) in solvent A (0.10/o [v/v] TFA in water) on a Waters 
Prep LC3000 system (Waters, Milford, MA). Peaks were eluted with a 
linear gradient of 80% (v/v) solvent B in solvent A to 100% solvent B 
over 20 min followed by 100% solvent B for 15 mm at a flow rate of 
50 ml/mm. Peaks were monitored at 220 nm. The fractions containing 
the desired lipitoid were combined and concentrated N1 vacua. Prod- 
ucts were characterized using analytical reverse-phase HPLC using a 
Vydac C4 column (5 pm, 300 A. 1 .O x 150 mm) on a MAGIC 2002 
lrquid chromatography system (Michrom BioResource, Auburn, CA) 
and electrospray ionization mass spectrometry (Platform II, Micromass, 
Bevely, MA). DPPE and DOPE were introduced using a similar method. 
Transfection assay 
Lipitoids were dissolved in sterile water at a concentration of 5 mM and 
sonicated for 1 min, resulting in clear stock solutions. In order to obtain 
the concentration of negative charge on plasmid DNA, average formula 
weight of 330 was used per nucleotide, corresponding 3.03 nmol of 
phosphate (or negative charge) per 1 pg DNA. Lipitoids were formally 
considered to be fully ionized to calculate a +/- charge ratio with DNA. 
The plasmid DNA stock solution and the lipitoid stock solution were 
diluted with OptiMEM to the desired concentration before formulation, 
and complex was prepared by mixing equal volumes of the DNA and lipi- 
toid solutions. All assays were performed in duplicate and the data were 
averaged. HT1080 and COSGM cells were maintained in DMEM supple- 
mented with 10% (v/v) FCS, 0.5 mM sodium pyruvate, and 2 mM L-gluta- 
mine. NIH3T3 cells were maintained in DMEM supplemented with 10% 
(v/v) calf serum. Two ml each of cell suspension (1 x 105cells/ml) was 
plated into a six-well plate 24 h prior to the transfection, and incubated in 
an atmosphere of 7% CO, at 37°C. Two hours prior to the addition of 
DNA to cells, the medium was completely removed from each well and 
replaced with 2 ml of DMEM containing 10% (v/v) FCS for serum posi- 
tive experiments. For serum-free experiments, wells were rinsed with 2 ml 
of OptiMEM, and another 2 ml of OptiMEM was added to each well. Lipi- 
toid-DNA complex was prepared to give a final DNA concentration of 
10 ug/ml, and 100 pl of the solution was added to each well within 
30 min after the preparation. The medium was completely removed from 
each well after incubation at 37°C for 3 h, and 2 ml of DMEM with 1 Oo/, 
(v/v) FCS was added. After incubation at 37°C for 48 h, the medium was 
discarded, and cells were rinsed with DPBS (2 x 2 ml). The cells were 
shaken in 300 pl of lysis buffer at 25°C for 15 to 20 min, transferred to an 
eppendorf tube using a cell scraper, and frozen and thawed quickly in an 
ethanol-dry ice bath. The cell lysate was centrifuged at 14,000 rpm for 
2 min. The firefly luciferase content of the supernatant was measured 
using a luciferase assay kit using a automated luminometer (Dynatech, 
ML2250, Chantilly, VA) according to the instructions provided by the 
manufacturer. The total protein content of the supernatant was deter- 
mined using BCA assay (Pierce BCA protein assay reagent). GFP 
expression was performed using pEGFP-Nl instead of pCMV-km-LUC 
in a similar manner without cell lysis, and evaluated using a Zeiss Axiovert 
135 microscope, light source and filter by following the instructions from 
Clontech. The toxicity of the transfection reagent was determined by 
visual examination of cells and by quantitating total protein recovered 
from cells 48 h post-transfection. 
Characterization of DNA-lipitoid complex 
Negative-stained transmission electron microscopy was performed using 
a Zeiss 1 OC transmission electron microscope. The sample solution was 
placed on a grid precoated with carbon and Formvar, and removed by 
blotting to a Kimwipe after 5min. To stain the sample, 4% aqueous 
uranyl acetate was placed on the grid for 2-5 s, removed by blotting and 
allowed to dry. Particle size of the complexes was measured by dynamic 
light scattering using a N4 Plus instrument (Coulter Corp., Miami, FL), 
and the zeta potential was determined by Doppler electrophoretic light 
scattering analysis using a Delsa 400SX instrument (Coulter Corp.) 
according to the instructions provided by the manufacturer, 
Agarose gel mobility shift assay 
Complexes containing 1 1-19 DNA (pCMV-km-LUC) with different 
amount of lipitoid were loaded onto a 1% agarose gel containing ethid- 
ium bromide, and electrophoresed at 70V for 1 h to examine the retar- 
dation of the plasmid DNA. 
DNase I protection assay 
DNA (pCMV-km-LUC, 10 pg) alone and DNA-lipitoid complexes con- 
taining the same amount of DNA with different amount of lipitoids were 
treated at 37°C with 10 units of DNasel in a total volume of 50~1 of 
10 mM aqueous MgCI, for 15 min. A 5 ~1 aliquot of reaction mixture was 
loaded with 1% SDS onto a 1% agarose gel containing ethidium bromide, 
and electrophoresed at 70V for 1 h to examine the integrity of the DNA. 
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